The immunomodulatory effects of antibiotics: In vitro and ex vivo investigations of 21 substances by means of the lymphocyte transformation test

Zentralblatt fur Bakteriologie

Volumn 284, Issue 2-3, 1996, Pages 402-438

  Schubert, Sabine ^a,e   Andresen, Bent Holger ^b   Bähr, Volker ^c   Fischer, Lutz ^d   Stamp, Reinhold ^e   Stricker, Gundolf ^f   Wittke, Johann Wolfgang ^g   Ullmann, Uwe ^a  

^a Kiel and Lungen Clinic Grosshansdorf   (Germany)

^b Ev luth Diakonissenanstalt   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

^f FRANZISKUS HOSPITAL   (Germany)

^g Friedrich Ebert Krankenhaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030199356     PISSN: 09348840     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0934-8840(96)80116-2     Document Type: Article

References (151)

1. Anderson, R., G. Grabow, R. Oosthuizen, A. Theron, and A. J. van Rensburg: Effects of sulfamethoxazole and trimethoprim on human neutrophil and lymphocyte function in vitro: In Vivo effects of co-trimoxazole. Antimicrob. Agents Chemother. 17 (1980) 322- 326
2. Andresen, B. H.: Einfluß von Antibiotika auf die Mitogen-induzierte und nicht stimulierte Transformation muriner Milzlymphozyten in vitro. Inauguraldissertation der CAU-Kiel, Kiel 1986
3. Ashman, R. F.: Lymphocyte Activation. In: W. E. Paul (ed.): Fundamental immunology, pp. 267-300. Raven Press, New York, 1984
4. Ba&hr, V. and R. Hänsel: Einfluß von Pilocarpin auf Zellproliferation und Konzentration von cyclischen Nucleotiden in murinen Milzzellkulturen. Arch. Pharmazie 313 (1980) 653-655
5. Bähr, V. and U. Ullmann: The influence of metronidazole and its two main metabolites on murine in vitro lymphocyte transformation. Eur. J. Clin. Microbiol. Infect. Dis. 2 (1983) 568-570
6. Balakrishnan, K. and L. E. Adams: The role of the lymphocyte in an immune response. Immunol. Invest. 24 (1995) 233-244
7. Banck, G. and A. Forsgren: Antibiotics and Suppression of Lymphocyte Function in Vitro. Antimicrob. Agents Chemother. 16 (1979) 554-560
8. Baum, M. K., J. J. Javier, Mantero-Atienza, R. S. Beach, M. A. Fletcher, H. E. Sauberlich, D. Feaster, and G. Shor-Posner: Zidovudine-associated adverse reactions in a longitudinal study of asymptomatic HIV-1-infectes homosexual males. J. Acquir. Immune Defic. Syndr. 4 (1991) 1218-1226
9. Becker, D., J. Katz, and J. Metz: Comparative effects of thiamphenicol and chloramphenicol on haemopoesis and lymphocyte transformation in vitro in man. Postgrad. Med. J. 50 (1974) 88-94
10. Beverley, P.: Tumorimmunologie. In: I. M. Roitt, J. Brostoff, D. Male (Hrsg.): Kurzes Lehrbuch der Immunologie. 3. Auflage, pp. 246-257. Georg Thicme Verlag, Stuttgart (1995)
11. Böyum, A.: Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest., 21, Suppl. 97 (1968) 77-82
12. Bowden, R. A., J. Digel, E. C. Reed, and J. D. Meyers: Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses. J. Infect. Dis. 156 (1987) 899-903
13. Bredberg, A., M. Brant, K. Riesbeck, Y. Azou, and A. Forsgren: 4-Quinolone antibiotics: positive genotoxic screening tests despite an apparent lack of mutation induction. Mutat. Res. 211 (1989) 171-180
14. Buimovica-Klein, E., M. Lange, W. G. Ramey, M. H. Grieco, and L. Z. Cooper: Cell- mediated immune response in AIDS. N. Engl. J. Med. 311 (1987) 328-329
15. Chaperon, E. A. and W. E. Sanders: Suppression of lymphocyte responses by cephalosporins. Infect. Immun. 19 (1978) 378-384
16. Chaperon, E. A.: Suppression of lymphocytes by cephalosporins. In: H. U. Eickenberg, H. Hahn, W. Opferkuch (eds.): The influence of antibiotics on host-parasite-relationship, pp. 22-31. Springer Verlag, Berlin (1982)
17. Collier, A. C., S. Bozzette, and R. W. Coombs et al.: A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N. Engl. J. Med. 323 (1990) 1015-1021
18. Dam, W. C., F. D. Malkinson, and H. Gewurz: The effect of common antibiotics on lymphocyte transformation. Experientia 31 (1975) 375
19. Damert, G. J. and P. G. Sohnle: Effect of chloramphenicol on in vitro function of lymphocytes. J. Infect. Dis. 139 (1979) 220-224
20. De Simone, C., L. Baldinelli, M. Ferrazzi, S. De Santis, L. Pugnaloni, and F. Sorice: Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis. J. Antimicrob. Chemother. 17 (1986) 811-814
21. Di Marco, R., I. Carrabba, V. Cavallaro, P. Zaccone, C. Stazzone, S. Franco, C. Coguzza, G. Nicoletti, and F. Nicoletti: The effect of cefepime on some immune parameters in vitro: Lack of interference with mitogen-induced lymphoproliferation, immunoglobulin synthesis, IFN-Gamma and IL-2 secretion and IL-2 receptor expression. J. Chemother. 5 (1993) 297-301
22. Drusano, G. L., H. C. Standifort, C. L. Bustamente, A. Forrest, G. Rivera, B. Tatem, and S. C. Schimpff: The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers. Eur. J. Clin. Microbiol. Infect. Dis. 3 (1984) 468-470
23. Field, A. K., M. E. Davies, C. DeWitt, H. C. Perry, and R. Liou et al.: {9-[2-hydroxy-1- (hydroxymethyl)ethoxy]methyl}guanine: A selective inhibitor of herpes group virus replication. Proc. Natl. Acad. Sci. USA 80 (1983) 4139-4143
24. Fischer, L.: Der Einfluß von Imipenem und Acyclovir auf die Transformation muriner Milzlymphozyten und humaner peripherer Blutlymphozyten. Inauguraldissertation der CAU-Kiel, Kiel 1989
25. Fischl, M. A., D. D. Richman, and M. H. Grieco et al.: The efficiacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-Related-Complex. N. Engl. J. Med. 317 (1987) 185-191
26. Fischl, M. A., C. B. Parker, and C. Pettinelli et al.: A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 323 (1990) 1009-1014
27. Forsgren, A. and G. Banck: Influence of Antibiotics on Lymphocyte Function in Vitro. Infect. 6, Suppl. 1 (1978) S91-S97
28. Forsgren, A., D. Schmeling, and G. Banck: Effect of antibiotics on chemotaxis of human polymorphonuclear leukocytes in vitro. Infect. 6 (1978) 102-106
29. Forsgren, A., G. Banck, H. Beckmann, and A. Bellahsène: Antibiotic-host defence interactions in vitro and in vivo. Scand. J. Infect. Dis., Suppl. 24 (1980) 195-203
30. Forsgren, A., A.-K. Bergh, M. Brandt, and G. Hansson: Quinolones affect thymidine incorporation into the DNA of human lymphocytes. Antimicrob. Agents Chemother. 29 (1986) 506-508
31. Forsgren, A., S. F. Schlossman, and T. F. Tedder: 4-Quinolone Drugs affect cell cycle progression and function of human lymphocytes in vitro. Antimicrob. Agents Chemother. 31 (1987) 768-773
32. Forsgren, A., A. Bredberg, and K. Riesbeck: Effect of ciprofloxacin on human lymphocateslaboratory studies. Scand. J. Infect. Dis., Suppl. 60 (1989) 39-45
33. Gallo, R. C., S. Z. Salahuddin, and M. Popovic: Frequent detection and isoltion of cytopathic retroviruses (HTLV III) from patients with AIDS and risk of AIDS. Science 224 (1984) 500-503
34. Gaylarde, M. and I. Sakany: Suppression of thymidine uptake of human lymphocytes by co-trimoxazole. Br. Med. J. 3 (1978) 144-146
35. Gergely, P., K. Nékàm, L. Kalmár, R. González-Cabello, and A. Perl: Ketoconazol in vitro inhibits mitogen-induced blastogenesis, antibody-dependent cellular cytotoxicity, natural killer activity and random migration of human leukocytes. Immunopharmacology 7 (1984) 167-70
36. Germain, R. N.: Modern concepts in immune recognition and lymphocyte activation. Relevance for the development of useful vaccines. Int. J. Technol. Assess. Health Care 10 (1994) 81-92
37. Gillissen, G.: Antibiotika und Immunantwort - Begleiteffekte der Chemotherapie. Immun. Infekt. 8 (1980) 79-88
38. Gillissen, G.: Non-Specific Influence of Antibiotics on the Course of Infectious Processes. Infection 10 (1982) 128-130
39. Gillissen, G.: Interaktion zwischen Antibiotika und Immunabwehr. In: C. Kraussmann (ed.): Neues von alten Erregern und neue Erreger, pp. 59-98. Walter de Gruyter Verlag, Berlin (1983)
40. Gismondo, M. R., G. Ghisari, and A. M. Lo Eue: Effect of ampicillin and sulbactam/ampicillin on the immune system. J. Int. Med. Res. 19 (Suppl. 1) (1991) 24A-28A
41. Goldstein, R. A., U. H. Ang, J. W. Foellmer, and B. W. Janicki: Rifampicin and cellmediated immune response in tuberculosis. Am. Rev. Respir. Dis. 113 (1976) 197-202
42. Gollapudi, S. V. S., R. H. Prabhala, and H. Thadepalli: Effect of Ciprofloxacin on mitogenstimulated lymphocyte proliferation. Antimicrob. Agents Chemother. 29 (1986) 337-338
43. Gollapudi, S. V. S., B. Vayuvegula, S. Gupta, M. Fok, and H. Thadepalli: Aryl- Fluoroquinolone derivatives A-56619 (Difloxacin) and A-56620 inhibit mitogen- induced human mononuclear cell proliferation. Antimicrob. Agents Chemother. 30 (1986) 390-394
44. Gootz, T. D., J. F. Barrett, and J. A. Sutcliffe: Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems. Antimicrob. Agents Chemother. 34 (1990) 8-12
45. Goverman, J., T. Hunkapiller, and L. Hood: A speculative view of Ro multicomponent nature of T cell antigen recognitio. Cell 45 (1986) 475-484
46. Grassi, G. C. and E. Pozzi: Effect of rifampicin on delayed hyper-sensitivity reactions. J. Infect. Dis. 126 (1972) 542-544
47. Guenounou, M., E. Ronco, E. Kodari, F. Vacheron, and V. Momrikof: Modulation de la réponse proliférative in vitro des cellules splénique de souris et de la production d'il 1 par les quinolones. Pathol. Biol. 35 (1987) 785-789
48. Hadden, J. W., R. G. Coffey, M. E. Hadden, E. Lopze-Corrales, and H. G. Sunshine: Effects of levainisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels. Cell. Immunol. 20 (1975) 98-103
49. Hadden, J. W.: The Immunopharmacology of Immunotherapy. Springer Seminars of Immunopathology 2 (1979) 35-48
50. Hahn, H., D. Kuhring, M. Trautmann, and T. Diamantstein: Einfluß von Cefaclor, Doxycyclin und weiteren oralen Antibiotika auf die Phagozytose polymorphkerniger Granulozyten und PHA-induzierte Stimulation von Blutlymphozyten des Menschen. Arzneim.-Forsch./Drag Res. 35 (I) (1985) 543-546
51. Hahn, H.: Kurzmitteilung über den Einfluß von Chinolon-Abkömmlingen auf das Immunsystem. Infection 14, Suppl. 3 (1986) S219
52. Hammarström, L. and E. Smith: Mitogenic properties of polyene antibiotics for murine B cells. Scand. J. Immunol. 5 (1976) 37-43
53. Heagy, W., C. Crumpacker, P. A. Lopez, and R. W. Finberg: Inhibition of immune functions by antiviral drugs. J. Clin. Invest. 87 (1991) 1916-1924
54. Hicks, M. J., R. M. Hagaman, and R. A. Barbee: Evaluation of methodologic variables of the in vitro lymphocyte transformation assay. Am. J. Clin. Path. 85 (1986) 704- 709
55. Hirschhorn, R. and K. Hirschhorn: Methods in Lymphocyte Transformation Studies. In: R. T. Cluskey, S. Cohen (eds.): Mechanisms of Cell-Mediated-Immunity. pp. 385-399. Wiley Biomedical Publication, New York (1974)
56. Hussy, P., G. Maas, B. Tümmler, F. Grosse, and U. Schomburg: Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob. Agents Chemother. 29 (1986) 1073-1078
57. Ibrahim, M. S., Z. A. Maged, A. Haron, R. Y. Khalil, and A. M. Attallah: Antibiotics and Immunity: Effects of Antibiotics an Mitogen Responsiveness of Lymphocytes and Interleukin-2 Production. Chemioterapia 7 (1988) 369-372
58. Ingham, E., L. Turnbull, and J. N. Kearny: The effects of minocycline and tetracycline on the mitotic response of human peripheral blood lymphocytes. J. Antimicrob. Chemother. 27 (1991) 607-617
59. Katz, D. R., M. Feldmann, R. Tees, and M. H. Schreier: Heterogeneity of accessory cells interacting with T-helper clones. Immunol. 58 (1986) 167-172
60. Kern, E. R.: Value of animal models to evaluate agents with potential activity against human cytomegalovirus. Transplant. Proc. 23, Suppl. 3 (1991) 152-155
61. Klaus, G. G. B. and C. M. Hawrylowicz: Cell-cycle control in lymphocyte stimulation. Immunology Today 5 (1984) 15-19
62. Kloppenburg, M., F. C. Breedveld, A. M. M. Miltenburg, and B. A. C. Dijkmans: Antibiotics as disease modifiers in arthritis. Clilnical and Experimental Rheumatology 11 (Suppl. 8) (1993) 113-115
63. Koch, R. L., B. B. Beaulieu, Jr., E. J. T. Chrystal, and P. Goldman: A metronidazole metabolite in human urine and its risk. Science 211 (1981) 398-400
64. Lane, H. C., J. M. Depper, W. C. Greene, G. Whalen, and T. Waldmann et al.: Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 313 (1985) 79-84
65. Langner, J.: Antigenprocessing and Antigenpräsentation durch akzessorische Zellen des Immunsystems. Allerg. Immunol. 31 (1985) 131-156
66. Larson, S. E., G. J. Damert, C. Collins-Lech, and P. G. Sohnle: Direct stimulation of lymphokine production by cephalothin. J. Infect. Dis. 142 (1980) 265-272
67. Levin, M. J., P. L. Leary, and R. D. Arbeit: Effect of acyclovir on the proliferation of human fibroblasts and peripheral blood mononuclear cells. Antimicrob. Agents Chemother. 17 (1980) 947-953
68. Leyhausen, G., G. Seibert, A. Maidhof, and W. E. G. Müller: Differential stimulation of lymphocyte cell growth in vitro by cephalosporins. Antimicrob. Agents Chemother. 26 (1984) 752-756
69. Luster, M. I., D. R. Germolec, K. L. White Jr., and B. A. Fuchs et al.: A comparison of three nucleoside analogs with anti-retroviral activity on immune and hematopoietic functions in mice: In vitro toxicity to precursor cells and microstromal environment. Toxicol. Appl. Pharmacol. 101 (1989) 328-339
70. Majeski, J. A., M. A. McCellan, and J. W. Alexander: Effect of antibiotics on the vitro neutrophil chemotactic response. The American Surgeon (1976) 785
71. Male, D. and I. Roitt: Erworbene und angeborene Immunität. In: I. M. Roitt, J. Brostoff, D. K. Male (Hrsg.): Kurzes Lehrbuch der Immunologie. 3. Auflage, pp. 1-11. Georg Thieme Verlag, Stuttgart, 1995
72. Maluish, A. E. and D. M. Strong: Lymphocyte proliferation. In: N. R. Rose, H. Friedman, J. L. Fahey (eds.): Manual of clinical laboratory immunology. 3. Auflage, pp. 274- 281. Am. Soc. of Microbiology, Washington D.C. (1986)
73. Manzella, J. P. and J. K. Clark: Effects of quinolones on mitogen-stimulated human mononuclear leucocytes. J. Antimicrob. Chemother. 21 (1988) 183-186
74. Martin, R. R., G. Warr, R. Couch, and V. Knight: Chemotaxis of human leucocytes: Responsiveness of mycoplasma pneumoniae. J. Lab. Clin. Med. 81 (1973) 520-529
75. McKallip, R. J., M. Nagarkatti, and P. S. Nagarkatti: Immunotoxicity of AZT: Inhibitory effect on thymocyte differentiation and peripheral T cellresponsiveness to gp 120 of human immunodefiency virus. Toxicol. Appl. Pharmacol. 131 (1995) 53-62
76. Miller, J. J., S. C. Reeves, and J. R. Salaman: Effects of simple imidazoles on human peripheral blood lymphocytes stimulated by mitogen or allogenic cells. J. Immunopharmacol. 2 (1980) 225-243
77. Mitsuya, H., K. J. Weinhold, P. A. Furmann, and S. St. Clair et al.: 3′-Azido-3′- deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Nad. Acad. Sci. USA 82 (1985) 7096-7100
78. Moosmann, E. B.: Weiteres AIDS-Medikament, Azidothymidin - Dideoxycytidin. Fortschr. Med. 110 (1992) 28-30
79. Moosmann, E. B.: Ist die frühzeitig kombinierte AIDS-Behandlung von Vorteil? Fortschr. Med. 111 (1993) 46
80. Moretta, L., M. Ferrarini, M. C. Mingari, A. Moretta, and S. R. Webb: Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J. Immun. 117 (1976) 2171-2174
81. Morikowa, K., F. Oseko, S. Morikawa, and M. Sawada: Immunosuppressive activity of fosfomycin on human T-Lymphocyte function in vitro. Antimicrob. Agents Chemother. 37 (1993) 2684-2687
82. Munch-Petersen, B.: Azidothymidine inhibits mitogen stimulated growth and DNA- repair in human peripheral lymphocytes. Biochem. Biophys. Res. Commun. 157 (1988) 1369-1375
83. Munster, A. M., C. B. Loadholt, A. G. Leary, and M. A. Barnes: The effect of antibiotics on cell mediated immunity. Surgery 81 (1977) 692-695
84. Murray, H. W., B. Y. Rubin, H. Masur, and R. B. Roberts: Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310 (1984) 883-889
85. Nilsson, B. S.: Rifampicin: An immunosuppresant? Lancet 2 (1971) 374 letter
86. Nokta, M. A. and R. B. Pollard: Differential reconstitution of zidovudine-induced inhibition of mitogenic responses by interleukin-2 in peripheral blood mononuclear cells from patients with human immunodeficiency virus infection. Antiviral Res. 11 (1989) 191-202
87. Oppenheim, J. J., S. Dougherty, S. P. Chan, and J. Baker: Use of Lymphocyte Transformation to assess clinical disorders. In: G. N. Vyas (edit.): Laboratory Diagnosis of Immunological Disorders, pp. 87-109. Green and Straton. New York (1975)
88. Padfici, R., A. Bacosi, A. Caronna, and S. Di Carlo et al.: Immunological consequences of zidovudine treatment in control and morphine or methadone treated mice. Immunopharmacol. Immunotoxicol. 14 (1992) 355-381
89. Palu, G., S. Valisena, M. Peracchi, and M. Palumbo: Do quinolones bind to DNA? Biochem. Pharmacol. 37 (1988) 1887-1888
90. Parker, J. W. and R. J. Lukes: A microculture method for lymphocyte transformation studies in the clinical laboratory. Amer. J. Clin. Path. 56 (1971) 174-180
91. Pasqui, A. L., M. Di Renzo, F. Brunt, G. Fanetti, G. Campoccia, and A. Auteri: Imipenem and immune response: in vitro and in vivo studies. Drugs Exp. Clin. Res. 21 (1995) 17-22
92. Peterson, P.K.: How antibiotics augment host defence. Fur. J. Clin. Microbiol. Infect. Dis. 1 (1982) 335-337
93. Petit, J. C., B. Burghoffer, G. Richard, and G. L. Daguet: Effect of imipenem (N- formimidoylthienamycin) on the in-vitro lymphocyte proliferation. J. Antimicrob. Chemother. 20 (1987) 871-874
94. Philips, N. C. and C. Tsoukas: Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against mutine acquired immuno- deficiency syndrome. Blood 79 (1992) 1137-1143
95. Pisciotta, A. V. and C. Deprey: Inhibition of mitosis by chloramphenicol in phytohemagglutinin stimulated lymphocytes. Blood 30 (1967) 457-464
96. Pocidalo, J. J., Y. Roche, and M.-A. Gougerot-Pocidalo: Quinolones et immunité - Effets de l'ofloxacine sur les réponses prolifératives des cellules mononuclées humaines. Comparaison avec la Ciprofloxacin et la Pefloxacin. Med. Maladies Infect. 16 (1986) 511-515
97. Potts, R. C., H. A. Hassan, R. A. Brown, A. MacConnachie, J. H. Gibbs, A. J. Robertson, and J. S. Beck: In vitro effects of doxycycline and tetracycline on mitogen stimulated lymphocyte growth. Clin. Exp. Immunol. 53 (1983) 458-464
98. Powrie, F. and R. L. Coffman: Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunology Today 14 (1993) 270-274
99. Pulverer, G., W. Roszkowski, H. L. Ko, K. Roszkowski, and J. Jeljaszewicz: Tierexperimentelle Untersuchungen zur Beeinflussung des Immunsystems durch Ofloxacin. Infect. 14, Suppl. 1 (1986) 40-44
100. Pulverer, G. and G. Peters: In Investigations on ofloxacin: antibacterial activity and influence on the immune system. Infect. 14, Suppl. 4 (1986) 245-247
101. Quinn, R. P., G. Wolberg, J. Medzihradsky, and G. B. Elion: Effect of Acyclovir on various murine in vivo and in vitro immunology assay systems. Am. J. Med. 73 (1982) 62-66
102. Raeburn, J. A.: Antibiotics and immunodeficiency. Lancet (1972) 954-956
103. Reitz, M., M. Rumpf, and R. Knitza: Metronidazole induces DNA strand-breaks in cultures of human lymphocytes and phytohemagglutinin-stimulated human lymphocytes. Arzneim.-Forsch./Drug Res. 41 (I) (1991) 65-69
104. Reitz, M., M. Rumpf, and R. Knitza: DNA single strand-breaks in lymphocytes after metronidazole therapy. Arzneim.-Forsch./Drug Res. 41 (II) (1991) 155-156
105. Richman, D. D., M. A. Fischl, and M. H. Grieco et al.: The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-Related-Complex. N. Engl. J. Med. 317 (1987) 192-197
106. Roche, Y., M. Fay, and M.-A. Gougerot-Pocidalo: Effects of quinolones on interleukin 1 production in vitro by human monocytes. Immunopharmacology 13 (1987) 99-109
107. Roselle, G. A. and C. A. Kauffmann: Amphotericin B and 5-fluorocytosine: in vitro effects on lymphocyte function. Antimicrob. Agents Chemother. 14 (1974) 398-387
108. Roszkowski, W., H. L. Ko, K. Roszkowski, J. Jeljaszewicz, and G. Pulverer: Antibiotics and immunomodulation: Effects of cefotaxime, amicacin, mezlocillin, piperacillin and clindamycin. Med. Microbiol. Immunol. 173 (1985) 279-289
109. Roszkowski, W., H. L. Ko, K. Roszkowski, P. Giborowski, J. Jeljaszewicz, and G. Pulverer: Effects of Ciprofloxacin on the humoral and cellular immune responses in Balb/c mice. Zbl. Bakt. Hyg. A 262 (1986) 396-402
110. Rouveix, B., and F. Chau: Action des Céphalosporines sur les lymphocytes T: rôle des médiateurs. Pathologie Biologie 35 (1987) 1450-53
111. Ruben, F. L., A. Winkelstein, and I. G. Fotiadis: Immunological responsiveness of tuberculosis patients receiving rifampicin. Antimicrob. Agents Chemother. 5 (1974) 383-387
112. Ruprecht, R. M., L. D. Bernard, T.-C. Chou, and M. A. Gama Sosa et al: Murine Models for evaluating antiretroviral therapy. Cane. Res. (Suppl.) 50 (1990) S5618-S5627
113. Rustia, M., P. Shubik: Induction of lung tumors and malignant lymphomas in mice by metronidazole. J. Natl. Cancer Inst. 48 (1972) 721-729
114. Rustia, M., P. Shubik: Experimental induction of hepatomas, mammary-tumors, and other tumors with Metronidazole in Noninbred-SAS-MRC(WI)BR-Rats. J. Natl. Cancer Inst. 63 (1979) 863-868
115. Said, H. E., Y. Khalil, and M. S. Sabbour: Comparative Study of 3 Aminioglycoside Antibiotics and Aztreonam on M.I.F. Production by spleenic Lymphocytes of Mice in Vitro. Chemotherapia 3 (1984) 232-234
116. Schmitt, K., W. Däubener, D. Bitter-Suermann, and U. Hadding: A safe and efficient method for elimination of cell culture mycoplasmas using ciprofloxacin. J. Immun. Meth. 109 (1988) 17-25
117. Schubert, S. and U. Ullmann: Effect od Antibiotics on Chemotaxis, Phagocytosis of Polymorphonuclear Leucocytes and Lymphocyte Transformation with special reference to Modern Beta-lactams and Fluorochinolones. In: U. Ullmann, A. Dalhoff (eds.): Significance of Cytokines in the Treatment of Infectious Diseases, pp. 111-137. Gustav Fischer Verlag Stuttgart (1993)
118. Schutt, C.: Zur Aussagekraft des Lymphozytentransformationstestes in der klinischen Diagnostik. Dissertation zur Erlangung des akademischen Grades Doktor der Wissenschaften, Rostock (1982)
119. Schütt, C.: Lymphozytentransformationstest (LTT). In: H. Friemet (Hrsg.): Immunologische Arbeitsmethoden. 3. Auflage, pp. 328-335. Gustav Fischer Verlag, Stuttgart (1984)
120. Serrou, B.: Rifampicin and immunosuppression. Lancet 2 (1974) 172 (letter)
121. Shalit, I.: Immunological aspects of new quinolones. Eur. J. Clin. Microbiol. Infect. Dis. 10 (1991) 262-266
122. Siegal, F.P., C. Lopez, G. S. Hammer, and A. E. Brown et al.: Severe acquired imunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N. Engl. J. Med. 305 (1981) 1439-1444
123. Shaw, D. R., D. R. Knight, D. R. Watermann, and J. P. Sommadossi: 3′-Azido-3′- deoxythymidine inhibition of human lymphocyte cytolytic function in vitro. Biochem. Pharmacol. 41 (1991) 287-291
124. Simecka, J. W., P. Patel, and E. R. Kern: Evaluation of immunotoxic potential of antiviral drugs. Effects of DHPG and HPMPC on lymphocyte transformation and delayed- type hypersensitivity (DTH) responses. Antiviral Res. 15, Suppl. 1 (1991) 150
125. Simecka, J. W., P. Patel, and E. R. Kern: Immunotoxic potential of antiviral drugs: effects of ganciclovir and (S)-1-(3-hydroxy-2-phosphonylmethoxy-prophyl)cytosine on lymphocyte transformation and delayed-type hypersensitivity responses. Antiviral Res. 18 (1992) 53-64
126. Simon, C. and W. Stille (Hrsg.): Antibiotika-Therapie in Klinik und Praxis. 8. Auflage, 32-35, 70-127, 231-258, 281-312, Schattauer Verlag, Stuttgart 1993
127. Smee, D. F., J. C. Martin, J. P. H. Verheyden, and T. R. Matthews: Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-Dihydroxy-2-propoxymethyl)guanine. Antimicrob. Agents Chemother. 23 (1983) 676-682
128. Smee, D. F., R. A. Burger, J. Coombs, J. H. Huffmann, and R. W. Sidwell: Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment. J. Infect. Dis. 164 (1991) 958-961
129. Smith, J. T.: Awakening the slumbering potential of the 4-quinolone antibacterials. Pharmaceut. J. 233 (1984) 299-305
130. Smith, J. T.: Wirkmechanismus der Quinolone. Infection 14. Suppl. 1 (1986) 3-15
131. Smith, J. T.: Interleukin-2: inception, impact, and implications. Science 240 (1988) 1169-1176
132. Stamp, R.: Beeinflußbarkeit der Phytohämagglutinin-induzierten Transformation muriner Milzlymphozyten durch Antibiotika verschiedener Hauptgruppen. Inauguraldissertation der CAU Kiel, Kiel 1990
133. .Steele, R. W., D. J. Marmer, and R. E. Keeney: Comparative immunotoxicology in vitro of acyclovir and other antiviral agents. Infect. Immun. 28 (1980) 957-962
134. Stetsenko, O. N., I. A. Pobery, M. I. Ulyanov, and D. P. Lindner: Tetracycline Effect on Immune and Hematopoetic Systems of Intact Rabbits. Antibiotiki 26 (1981) 856-860
135. Stobo, J. D., A. S. Rosenthal, and W. E. Paul: Functional heterogeneity of murine lymphoid cells: I. Responsiveness to and surface binding of Concanavalin A and Phytohemagglutinin. J. Immunool. 108 (1972) 1-17
136. Strome, S. E., J. C. Krauss, A. E. Chang, and S. Shu: Strategies of lymphocyte activation for the adoptive immunotherapy of metastatic cancer: a review. J. Hematother. 2 (1993) 63-73
137. Stünkel, K. G. E., G. Hewlett, and H. J. Zeiler: Ciprofloxacin enhances T cell function by modulating interleukin activities. Clin. Exp. Immunol. 86 (1991) 525-531
138. Tärnvik, A. and S. Ǎnséhn: Effect of amphotericin B and Clotrimazole on Lymphocyte stimulation. Antimicrob. Agents Chemother. 6 (1974) 529-533
139. Tauris, P., B. Moller, C. M. Petersen, and F. T. Black: Effects of 3′-azido-3′- deoxythymidine (AZT) on short-term cultured human peripheral blood lymphocytes. Eur. J. Clin. Invest., 19 (1989) 167-171
140. Thong, Y. H. and A. Ferrante: Inhibition of mitogen-induced human lymphocyte proliferative response by tetracycline analogues. Clin. Expl. Immunol. 35 (1979) 443-446
141. Van den Bogert, C., T. E. Melis, and A. M. Kroon: Mitochondrial Biogenesis during the Action of Lymphocytes by Mitogens: The Immunosuppressive Action of Tetracyclines. J. Leucocyte Biol. 46 (1989) 128-133
142. Walter E.: Rangsummentest für unverbundene Stichproben. In: Biomathematik für Mediziner. 2. Auflage, pp. 130-132. Teubner Studienbücher Mathematik. B.G. Teubner Verlag, Stuttgart (1980)
143. Warrier, I. and J. M. Lusher: Retrovir therapy in hemophilic children with symptomatic human immunodeficiency virus infection: efficacy and toxicity. Am. J. Pedriat. Hematol. Oncol. 12 (1990) 160-163
144. Weinstein, L. and A. C. Dalton: Host determinants of response to antimicrobial agents. N. Engl. J. Med. 279 (1968) 580-588
145. Wilde, M. I. and H. D. Langtry: Zidovudine - An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 46 (1993) 515-578
146. Williams, W. R. and B. H. Davies: Modulation of lymphocyte adrenergic receptors and transformation responses by therapeutic drugs. J. Clin. Lab. Immunol. 13 (1984) 29- 34
147. Wingard, J. R., A. D. Hess, R. K. Stuart, R. Saral, and W. H. Burns: Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation. Antimicrob. Agents Chemother. 23 (1983) 593-597
148. Wojtulewicz-Kurkus, J., E. U. Skopinska-Rozewska, M. Norwacyk, and I. Podbinska: The effect of ampicillin on the response of human lymphocytes to PHA. Arch. Immunol. Ther. Exp. 29 (1981) 361-368
149. Yarchoan, R., K. J. Weinhold, and H. K. Lyerly et al.: Administration of 3′-azido-3′- deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-Related-Complex. Lancet 1 (1986) 575-580
150. Yarchoan, R., R. Thomas, and J. P. Allain et al.: Phase I studies of 2′-3′-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet 1 (1988) 76-81
151. Zehavi-Willner, T. and I. Shalit: Enhancement of interleukin-2-production in human lymphocytes by two new quinolone derivatives. Lymphokine Res. 8 (1989) 35-46